Paroven (Zyma) is a mixture of hydroxyethyl rutosides marketed for the relief of ‘chronic venous insufficiency’ of the lower limb. On the European mainland, where most of the published observations with it were made, it is sold under the name Venoruton. The Macgregor Committee has classified Paroven in category B2, i.e. of unproven efficacy.1
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.